PET scan for planning radiation in meningioma
Part of Brain & nervous system, Cancer clinical trials.
This study uses a special PET scan (DOTATATE) to help doctors plan radiation treatment for meningioma, a type of brain tumor. The scan may help target radiation more precisely, potentially improving outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a meningioma (a brain tumor) that needs radiation, either after surgery or as the main treatment.
- You have not had radiation or medical therapy for this tumor before.
- You are not pregnant or breastfeeding.
- You can lie still for the scan and do not have severe claustrophobia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
This trial tests how well a special scan (Ga-68 DOTATATE PET combined with MRI) helps diagnose and guide treatment for certain brain tumors that have somatostatin receptors. It may help doctors better find tumor recurrence or remaining tumor after treatment.
This trial tests a special imaging agent called [Cu64]DOTATATE that helps surgeons see meningioma tumors during surgery. It may make tumor removal more complete and safer.
This study uses a special PET scan to see if your recurrent meningioma has a protein called PSMA. This could help decide if a new treatment that targets this protein might work for you.
This trial tests a new type of MRI scan that may help see meningioma brain tumors more clearly. It is a short imaging study for people who plan to have surgery or monitoring.
This Phase 1/2 study tests a targeted radioactive medicine (Lu-177-satoreotide) for meningiomas that keep coming back or keep growing. It works only if tumor imaging shows the tumor has the right “target” signal, and it aims to see how well it can control the disease and how safe it is.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.